We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Bionano Genomics Inc | NASDAQ:BNGO | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.0403 | -3.77% | 1.0297 | 1.02 | 1.03 | 1.10 | 1.02 | 1.08 | 815,771 | 00:04:50 |
•
|
the size and growth potential of the markets for our products, and our ability to serve those markets;
|
•
|
the impact of the COVID-19 pandemic on our business and operations;
|
•
|
the rate and degree of market acceptance of our products;
|
•
|
ability to expand our sales organization to address effectively existing and new markets that we intend to target;
|
•
|
impact from future regulatory, judicial, and legislative changes or developments in the U.S. and foreign countries;
|
•
|
ability to compete effectively in a competitive industry;
|
•
|
the success of competing technologies that are or may become available;
|
•
|
the performance of our third-party contract sales organizations, suppliers and manufacturers;
|
•
|
our ability to attract and retain key scientific or management personnel;
|
•
|
the accuracy of our estimates regarding expenses, future revenues, reimbursement rates, capital requirements and needs for additional financing;
|
•
|
our ability to comply with the covenants and satisfy certain conditions of our debt facility;
|
•
|
our ability to obtain funding for our operations; and
|
•
|
our ability to attract collaborators and strategic partnerships.
|
•
|
Get the Service. Customers can submit samples to Bionano Data Services and receive an appropriately filtered set of structural variant calls. Structural variation data is then presented using the Bionano Access visualization software, and files can be exported in the format of choice. Pricing for this service is $650 per genome for standard samples and $750 per genome for mosaic and cancer samples.
|
•
|
Get the Consumables. For customers who commit to purchase at least 120 genomes every six months, the Bionano Support team will install the Saphyr System on the customer’s premises and provide training on sample preparation, instrument operation and data analysis. Pricing for this service is $550 per genome, with installation and training included at no cost, and the Saphyr instrument made available at no charge for the duration of the customer’s project.
|
•
|
Get the Saphyr System. For customers who purchase the Saphyr System, the Bionano Support team will install the Saphyr System and provide training on sample preparation, instrument operation and data analysis. Pricing begins at $150,000 for the Saphyr instrument, $550 per genome or $450 per genome with a 240 genome bundle, with installation and training included at no cost.
|
•
|
2,987,691 shares of common stock issuable upon the exercise of options outstanding as of June 30, 2020 at a weighted average exercise price of $3.34 per share;
|
•
|
5,343,380 shares of common stock reserved for future issuance under our 2018 Equity Incentive Plan as of June 30, 2020;
|
•
|
341,427 shares of common stock reserved for future issuance under our 2018 Employee Stock Purchase Plan as of June 30, 2020;
|
•
|
75,414,050 shares of common stock issuable upon the exercise of common warrants outstanding as of June 30, 2020 at a weighted-average exercise price of $0.80 per share, under which 42,005,000 shares of common stock have been issued between July 1, 2020 and August 12, 2020; and
|
•
|
4,500,000 shares of common stock issuable upon the exercise of pre-funded warrants outstanding as of June 30, 2020 at a weighted-average exercise price of $0.001 per share, under which 4,500,000 shares of common stock have been issued between July 1, 2020 and August 12, 2020.
|
Assumed offering price per share
|
| |
|
| |
$0.77
|
Historical net tangible book value per share as of June 30, 2020
|
| |
$0.06
|
| |
|
Increase in as adjusted net tangible book value per share attributable to this offering
|
| |
0.25
|
| |
|
As adjusted net tangible book value per share after giving effect to this offering
|
| |
|
| |
0.31
|
Dilution per share to new investors in this offering
|
| |
|
| |
0.46
|
•
|
2,987,691 shares of common stock issuable upon the exercise of options outstanding as of June 30, 2020 at a weighted average exercise price of $3.34 per share;
|
•
|
5,343,380 shares of common stock reserved for future issuance under our 2018 Equity Incentive Plan as of June 30, 2020;
|
•
|
341,427 shares of common stock reserved for future issuance under our 2018 Employee Stock Purchase Plan as of June 30, 2020;
|
•
|
75,414,050 shares of common stock issuable upon the exercise of common warrants outstanding as of June 30, 2020 at a weighted-average exercise price of $0.80 per share, under which 42,005,000 shares of common stock have been issued between July 1, 2020 and August 12, 2020; and
|
•
|
4,500,000 shares of common stock issuable upon the exercise of pre-funded warrants outstanding as of June 30, 2020 at a weighted-average exercise price of $0.001 per share, under which 4,500,000 shares of common stock have been issued between July 1, 2020 and August 12, 2020.
|
•
|
our Annual Report on Form 10-K for the year ended December 31, 2019 filed with the SEC on March 10, 2020;
|
•
|
our Quarterly Reports on Form 10-Q for the quarter ended March 31, 2020 and June 30, 2020 filed with the SEC on June 18, 2020 and August 13, 2020, respectively;
|
•
|
our Current Reports on Form 8-K (other than information furnished rather than filed) filed with the SEC on January 30, 2020, March 2, 2020, April 6, 2020, April 20, 2020, April 24, 2020, May 5, 2020, May 14, 2020, June 19, 2020, July 2, 2020, August 14, 2020, August 24, 2020 and August 26, 2020; and
|
•
|
the description of our common stock which is registered under Section 12 of the Exchange Act, in our registration statement on Form 8-A, filed on August 17, 2018, including any amendment or reports filed for the purposes of updating this description.
|
1 Year Bionano Genomics Chart |
1 Month Bionano Genomics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions